50
Participants
Start Date
July 20, 2023
Primary Completion Date
November 1, 2026
Study Completion Date
November 1, 2027
Lenvatinib
Lenvatinib 12 mg (body weight 60 kg or greater) or 8 mg (body weight \< 60 kg) once orally every day
Asan Medical Center, Seoul
Lead Sponsor
Eisai Inc.
INDUSTRY
Chonnam National University Hospital
OTHER
Seoul National University
OTHER
Gangneung Asan Hospital
OTHER
Ulsan University Hospital
OTHER
Chosun University Hospital
OTHER
Dong-A University Hospital
OTHER
Bundang CHA Hospital
OTHER
Seoul National University Bundang Hospital
OTHER
Yonsei University
OTHER
Hanyang University Seoul Hospital
OTHER
Chungnam National University Hospital
OTHER
Saint Vincent's Hospital, Korea
OTHER
Gyeongsang National University Hospital
OTHER
Ewha Womans University
OTHER
Chungbuk National University Hospital
OTHER
Severance Hospital
OTHER
Gachon University Gil Medical Center
OTHER
The Catholic University of Korea
OTHER
Bucheon St. Mary's Hospital
OTHER
Asan Medical Center
OTHER